DTx Product Profile

Sleepio®

Sleepio helped 76% of patients achieve clinical improvement in insomnia.

Product Highlight

Condition targeted:

Insomnia

How it works:

Sleepio is a digital sleep improvement program accessible through mobile and web, and clinically proven to help you clear your mind, improve your sleep, and have better days.

Impact:

Sleepio helped 76% of patients achieve clinical improvement in insomnia.

Overview

Medical condition:

Insomnia

Target patient population:

Patients who desire recovery from insomnia.

What to expect:

Sleepio demonstrated in a placebo-controlled RCT and a further 11 published RCTs that Sleepio helped 76% of patients achieve clinical improvement in insomnia.
Health economic data also suggest that Sleepio is associated with $1,677 reductions in healthcare costs.

Clinical Overview

Indications for use:

Sleepio is a digital therapeutic intended for the improvement of poor sleep and the management of insomnia disorder in adults aged 18 years and older, as an adjunct to their usual medical care.
For adults diagnosed with insomnia disorder, Sleepio should be used under the supervision of a healthcare professional.
For otherwise healthy adults who have difficulty sleeping, Sleepio may be used as a non-prescription self-help tool to improve sleep health.

Outcomes:

Sleepio helped 76% of patients achieve clinical improvement in insomnia.

Directions:

The Sleepio program consists of six sessions (each 20 minutes on average) which can be completed in weeks, and daily Sleep Diary entries (<5 minutes each).

Each of Sleepio’s six sessions builds on the last, guiding users step by step through methods proven to help them quiet their racing mind, reshape their behaviors, and get better sleep — all in about 20 minutes per week. Sleep Diary entries enable Sleepio to help the user track their progress over the course of the program.

Risks & warnings:

Sleepio may not be suitable for people without internet, wifi, or a mobile device. Sleepio is a digital therapeutic intended for the improvement of poor sleep and the management of insomnia disorder in adults aged 18 years and older, as an adjunct to their usual medical care.

Place in therapy:

Complimentary to current therapy and effective as a standalone solution.

Product Access

Product description:

Sleepio is a digital sleep improvement program accessible through mobile and web, and clinically proven to help you clear your mind, improve your sleep, and have better days.

Prescription status:

No prescription is required.

Patient access:

Eligible users can sign up for Sleepio on web (desktop or mobile), at which point they can start the program by either downloading the mobile app (currently iOS users only) and logging in, or continuing on web (desktop or mobile).Use of this product requires access to:

Provider access:

Sleepio provides a non-drug alternative for insomnia without needing a prescription. In the UK, Sleepio is available for eligible individuals through self-referral or by visiting their GP.

Coverage options:

In the US, Sleepio is offered through large payers including self-insured employers. Sleepio is offered to millions of people in the UK through their NHS services.

Product availability:

Sleepio is available in:

Unique Features.

Through a strategic collaboration with CVS, Big Health pioneered billing through the PBM, which allows people to pay for digital therapeutics in a similar way to how they pay for drugs.

Clinical Trials

Copyright © 2021 Digital Therapeutics Alliance™